GLP-1 drugs appear psychiatrically safe, but one finding still raises questions
With millions of patients now taking GLP-1 drugs, researchers examined whether concerns about depression and suicidality are supported…
Probiotics for mental health? A new review finds promising signals and major gaps
Researchers map the probiotic strains and gut-brain pathways being investigated across anxiety, depression, bipolar disorder, and schizophrenia, revealing…
Single-dose psilocybin shows promise for treatment-resistant depression in NHS trial
A 25-mg dose of psilocybin paired with psychological support produced large improvements in depressive symptoms through six weeks,…
Major VA study to examine effectiveness of psilocybin on depression, PTSD
The Department of Veterans Affairs is launching research to determine whether psilocybin — the psychoactive ingredient in “magic…
Lilly to buy psychedelic-drug firm AtaiBeckley
The pharma giant Eli Lilly and Company has agreed to buy the biotech firm AtaiBeckley, expanding its…
GLP-1 receptor activation linked to lower depression and bipolar disorder odds
Lifelong genetic differences associated with GLP-1 receptor activity point to possible mental health benefits beyond weight and glucose…
Neumora Ends Depression Drug Programme and Announces Workforce Reduction (NMRA)
medical research red syringe NEW SIZE ©rawpixel Neumora Therapeutics (NASDAQ:NMRA) said on Monday that it will halt development…
Scientists introduce a precise framework to study screen-saturated childhoods
Children are growing up inside screens. A new peer-reviewed Thought Leaders Invited Review in Brain Health argues that…
Ghrelin rises in depression despite obesity’s usual appetite-hormone suppression
A new study finds elevated active and deacylated ghrelin in unmedicated patients with both major depression and obesity,…
How could bisphenol A raise depression risk? Study identifies six key molecular targets
Researchers combined genetic epidemiology, transcriptomics, molecular docking, and mouse experiments to show how a common endocrine-disrupting chemical may…
Depression’s “Energy Crisis”: Fatigue Starts at the Cellular Level
Summary: Fatigue is one of the most debilitating and hardest-to-treat symptoms of major depressive disorder (MDD). New research…
Simple wrist-worn device enables early detection of depression relapse
Could a smart watch act as an early‑warning system for depression relapse? New research from McMaster University suggests…